Annual
`Report
`2005
`
`(w
`
`EUROPEAN
`SOCIETY OF
`CARDIOLOGY ®
`
`Liquidia's Exhibit 1105
`Page 1
`
`

`

`President
`and
`Chief
`Executives’
`Report
`to
`Members
`
`Liquidia's Exhibit 1105
`Page 2
`
`

`

`pPresident and Chief Executives’ Report to Members
`
`The new Board, appointed in September 2004, continues to work on the strategic
`objectives set up in 2003, and has initiated the discussion on the new strategic vision.
`
`The structure of the Constituent Bodies of the ESC continues to evolve. Four
`Associations are now active. In addition to the European Heart Rhythm Association
`(EHRA) and the European Association of Echocardiography (EAE), two new
`associations were officially launched at the ESC Congress in Munich in August 2004.
`The European Association for Cardiovascular Prevention and Rehabilitation (EACPR)
`was formed out of the merger of the two Working Groups: WG on Cardiac
`Rehabilitation and Exercise Physiology and WG on Epidemiology and Prevention.The
`Heart Failure Association of the ESC evolved from the now dissolved ESC Working
`Group on Heart Failure. All associations enjoy a rapid growth and substantially
`contribute to the development of respective subspecialties in Europe.
`
`The Councils of the ESC are designed to provide horizontal integration of diverse
`activities within the ESC and reach out to sister organisations to achieve Europe-
`wide cooperation on key issues. Creation of the Council on Basic Cardiovascular
`Science enhanced the role of science within the Society and enabled effective
`interaction with other European professional organisations of this kind.
`
`In March the ESC launched an important initiative,“Women at Heart”.This initiative
`is aimed at medical professionals, to highlight the growing burden and under-
`appreciation of heart disease in women, and promote improved handling of women
`at risk of cardiovascular disease in clinical practice. Women are also under-
`represented in clinical trials. There is thus much to be done to increase the
`understanding of women’s CVD and to improve the quality of treatment of women
`with CVD across Europe. This year “Women at Heart” includes three main
`components – a successful Policy Conference on cardiovascular disease in women
`took place at the Heart House in June 2005; a horizontal analysis of data collected
`within the Euro Heart Survey programme will be carried out, and women’s heart
`health has been chosen as the leading topic of the Annual Congress at Stockholm.
`
`Congresses
`Last year’s congress in Munich was extremely successful, both in terms of the number
`of participants and the scientific level of the event. Many features that contributed to
`this success, such as the FOCUS sessions, basic science track, as well as the Hotline
`
`3
`
`Liquidia's Exhibit 1105
`Page 3
`
`

`

`and Clinical Update sessions will be continued this year.The layout and presentation
`format of the electronic posters will be improved, to meet the expectations of both
`the presenters and the participants. New features this year will include Science
`Hotline, where for the first time the most recent data on basic and clinical science
`will be presented, and also Meet-the-Expert sessions, addressing practical issues
`related to the management of important clinical problems. All sessions on
`cardiovascular health in women will be highlighted in the programme.
`An all-time record number of abstracts was submitted this year from all over the
`world, which has led us to increase the number of oral and poster presentations.
`The subspecialty congresses also continue to attract more delegates each year, both
`in absolute numbers and geographic representation. Heart Failure, Euroecho and
`Europace congresses have all been very successful, recording excellent levels of
`participation. Also the meetings organised by the Working Groups attract the
`attention of many cardiologists.We believe that the interest in these events will grow,
`as the cardiology community becomes more specialised in the future.
`
`Journals
`European Heart Journal and Cardiovascular Research, the two official ESC journals,
`continue to be successful.The impact factor of the European Heart Journal reached
`6.247 this year, the highest value ever.The family of subspecialty journals, including the
`European Journal of Heart Failure, Europace, European Journal of Echocardiography,
`European Journal of Cardiovascular Nursing, European Journal of Cardiovascular
`Prevention and Rehabilitation, is now well established on the market, and covers a
`wide range of topics related to cardiovascular medicine.
`
`Guidelines
`Production of practice guidelines continues to be one of the core activities of the
`ESC. A set of core guidelines covering most relevant areas in clinical practice, was
`established.The core guidelines will be updated on a regular basis.
`Five new documents have been published since the last Annual Congress. A wide
`variety of topics was covered, including syncope, primary pulmonary hypertension,
`acute and chronic heart failure, and percutaneous coronary interventions. All
`guidelines are developed in close collaboration with all ESC constituent bodies, and
`a majority of National Societies endorse the ESC guidelines.Translations into several
`different languages, prepared by the National Societies, are now available. Each
`guideline is accompanied by a pocket version and also comes in the PDA format,
`
`4
`
`Liquidia's Exhibit 1105
`Page 4
`
`

`

`increasingly serving as a useful tool,
`practice.
`
`improving patient care in everyday clinical
`
`Euro Heart Survey
`The programme has been simplified and refined. The second surveys on acute
`coronary syndromes and on heart failure are in progress. The survey on
`percutaneous coronary interventions was launched in May, generating a lot of
`attention in different countries, which should ensure adequate representation of all
`geographic areas. Several other surveys are in the pipeline. Unified sets of data,
`produced for the European Union by the ESC experts within the CARDS
`programme (Cardiology Audit and Data Standards) are implemented in all surveys,
`in order to make possible data comparison between different countries. In the new
`surveys, all participating centres will get feedback on their own performance as
`compared to other centres.This approach, we hope, will represent an added value
`to the contributors.
`
`Continuing Medical Education
`The ESC has produced several educational products over the last year, including
`CDs, DVDs, and a new book on cardiovascular imaging.
`The Educational Web Site of the Society, www.ESCed.org, offers a number of case-
`based modules for training and self-assessment. This site is free to all users.
`A most important project which will be completed by the ESC this year is the
`development of the ESC Textbook of Cardiovascular Medicine.This textbook will be
`based largely on the Core Curriculum and will be a useful addition to every
`cardiologist's library.The textbook is being written mostly by European cardiologists
`for a wide audience, and will provide the most up-to-date review for identifying and
`managing cardiovascular diseases.The textbook will be available both in printed and
`electronic format in November 2005.
`The number of educational courses has been reduced, and the emphasis was placed
`on the update meetings, covering the entire spectrum of cardiology.The first meeting
`of this kind was organised jointly with the Erasmus University earlier this year.
`All educational products and events are accredited by the European Board for
`Accreditation in Cardiology (EBAC) for CME activity, and an increasing number of
`requests for EBAC accreditation are received for meetings from around the world.
`Accreditation of individuals in different cardiac subspecialties has been initiated by
`the European Board for Specialty in Cardiology (EBSC), in close collaboration with
`
`5
`
`Liquidia's Exhibit 1105
`Page 5
`
`

`

`the Associations and Working Groups, as well as all interested National Societies.The
`first examinations were given in echocardiography, electrophysiology and pacing, and
`preparations are well advanced in other areas, such as interventional cardiology.
`
`Training and Research Fellowships
`The number and scope of Training Fellowships has been dramatically enlarged,
`showing the ESC commitment to encourage the exchange of knowledge and
`increase contacts between young cardiologists from different member countries.This
`year the ESC Board also decided to re-establish the Research Fellowships for young
`investigators. Both the Working Groups and Associations have largely contributed to
`the success of both programmes.
`
`External and Industry Relations
`The ESC enjoys amicable and productive relations with a range of related
`Organisations, including the North American cardiology organisations - the American
`College of Cardiology (ACC) and American Heart Association (AHA), the World
`Heart Federation (WHF), with whom we are cooperating in significant ways, and the
`European Heart Network (EHN), European Atherosclerosis Society (EAS),
`European Society of Hypertension (ESH), to mention but a few.These relations help
`to build a network based on a common interest, for the benefit of our common
`discipline, and thereby, for the benefit of our patients.
`Important collaboration has been developed between the ESC and EuroPCR (Paris
`Course on Revascularisation), including the launch of EuroIntervention, a EuroPCR
`journal endorsed by the ESC Working Group on Interventional Cardiology.
`
`The Cardiovascular Round Table (CRT) is a strategic forum for high level dialogue
`between the European Society of Cardiology and the industry, where
`representatives of the ESC and the major drug, device and equipment companies
`can exchange ideas and build common projects for the future.The main aim of the
`CRT is to provide a political platform to achieve recognition of the importance of
`cardiovascular health in Europe. Several CRT-related Task Forces exist to address
`specific issues such as patient access to healthcare, regulatory aspects of clinical trials,
`prevention policies, etc.The activities of the CRT have helped to create new relations
`with such organisations as the European Medicines Evaluation Agency (EMEA).
`Recently the scope of the activities of the CRT has been enlarged by the creation of
`a new Task Force on Cardiovascular Research in Europe. Clinical investigation and
`translational research in particular seem to be jeopardized, and this Task Force will
`
`6
`
`Liquidia's Exhibit 1105
`Page 6
`
`

`

`work in synergy with the ESC Committee for European Affairs in order to promote
`funding for cardiovascular research in Europe.
`We hope that the CRT will continue to flourish in the future and that the sharing of
`ideas and information will give rise to further productive initiatives to the benefit of
`European healthcare.
`
`European Union Relations
`The main objectives of the ESC-EU relations are to influence the European political
`agenda on cardiovascular disease, and to act as an exchange facilitator between
`constituent bodies of the ESC and European Institutions for all matters related to
`cardiovascular diseases.
`
`In June 2004, the Council of Health Ministers of the European Union adopted
`conclusions on cardiovascular health. In order to follow up on the impact of these
`conclusions on national policies, the Heart Health Conference was held on June 29,
`2005 in Luxembourg, co-organised by the European Commission, the Luxembourg
`Ministry of Health and the ESC.The objective of this meeting was to form a heart
`alliance between the cardiac society and the ministry of health in each EU country.
`
`Other activities in this area included support to the Framework Programme 7, and
`building up plans for developing the Women at Heart initiative.
`The conclusions of the conference on the future of cardiovascular research in
`Europe, held in 2004, generated a wide variety of possible projects that the European
`Commission might be willing to support, and gave material to help influence the
`content of Framework Programme 7 (2006-2010),
`in particular priorities and
`funding.
`
`Excellent support from the National Societies was provided for all EU-related
`projects.
`
`Finances
`The Treasurer and Auditors’ Report at the end of this document shows that the
`operating results for the past year are very satisfactory, with a significant surplus
`which will help to reinforce the financial underpinning of the Society.The quality of
`financial information now available to the Board, the Audit Committee and all the
`constituent bodies is excellent, which facilitates decision making and planning.
`
`7
`
`Liquidia's Exhibit 1105
`Page 7
`
`

`

`ESC 2004-2005
`This overview, complemented by more detailed information in the other chapters of
`this Annual Report, shows how the ESC is proceeding to meet its strategic
`hhiliRMil nrnii
`objectives. The Committees, the ESC Business Units, the Associations, Working
`Groups and other components of the ESC, will all have their role to play in
`implementing these objectives.
`
`We are grateful for the contribution of many people – scientists, cardiologists, nurses
`and other professionals who continue to drive forward the programmes and
`activities of the ESC, and for the enthusiastic support of the dedicated staff. It has
`been and continues to be a pleasure to work with all of you.We are convinced that
`our mutual efforts will help to improve the quality of life in the European population
`by reducing the impact of cardiovascular disease.
`
`a.
`
`-
`
`Michal TENDERA
`ESC President, 2004-2006
`
`Alan J. HOWARD
`ESC Chief Executive
`
`8
`
`Liquidia's Exhibit 1105
`Page 8
`
`

`

`
`
`ESC Board 2004-2006
`ESC Board 2004-2006
`
`Liquidia's Exhibit 1105
`Page 9
`
`Liquidia's Exhibit 1105
`Page 9
`
`

`

`Report
`on ESC
`Activities
`
`Report
`on
`ESC
`Activities
`
`Liquidia's Exhibit 1105
`Page 10
`
`

`

`eLess than two years after its creation, EHRA has become the recognised professional
`
`authority in cardiac arrhythmia in Europe. Over the last months 1,000 members have
`joined the Association.The varied activities and areas of interest of the Association’s
`committees are described on the dedicated website www.escardio.org/EHRA.
`
`European Heart Rhythm Association (EHRA)
`
`The Association participates actively in the scientific programmes of the ESC,
`particularly Guidelines. There are also several parallel interests and important
`exchanges with the other sub-specialty Associations of the ESC, as well as with the
`Heart Rhythm Society of North America.
`
`The Europace 2005 was held in Prague at the end of June and attracted over 3,400
`attendees, including an important exhibition.
`
`The first EHRA accreditation examinations in invasive cardiac electrophysiology and
`in cardiac pacing were held at the time of Europace. This reflects a major step
`forward for EHRA led by a small group of dedicated EHRA leaders.
`
`The Europace Journal has achieved an impact factor of 1.176 and is flourishing,
`becoming a monthly issue soon.
`
`The Executive Board of EHRA completed its initial term of office at the end of the
`General Assembly held in Prague.The new Executive Board was elected directly by
`members for a two year term and comprises: S. Priori (President),
`J. Brugada
`Terradellas (President-Elect and Chair of Scientific Committee), H. Crijns (Treasurer),
`P. Vardas (Secretary).
`
`EUROPEAN
`Heat Rhythm
`ASSOCIATION
`
`The previous Executive Board expresses its appreciation to all those members and
`supporters who have enabled EHRA to commence the realisation of its mission
`which remains to improve the quality of life of the European population by reducing
`the impact of cardiac arrhythmias.
`
`Lukas Kappenberger
`President, European Heart Rhythm Association
`
`12
`
`Liquidia's Exhibit 1105
`Page 11
`
`

`

`eEuropean Association of Echocardiography (EAE)
`
`The European Association of Echocardiography continues to grow with enthusiastic
`support from the national societies of echocardiography.We look forward to a more
`efficient management with the establishment in July 2005 of our own office in the
`European Heart House.
`
`EUROPEAN
`ASSOCIATION OF
`Echocardiography
`A RtQltt&ed Brand, ON the (SC
`
`Euroecho 8 in Athens in December 2004 was our largest and most successful
`conference yet with attendance of over 2,250. The financial success of the meeting
`has enabled us to embark on more programmes to fulfil our objectives “to promote
`excellence in clinical diagnosis, research, technical development, and education in
`cardiovascular ultrasound in Europe”. Euroecho 9 in Florence in December 2005
`promises even greater success since a record number of abstracts was submitted.
`The EAE is planning an extramural programme with teaching courses in Eastern
`Europe and North Africa in 2006, and we are developing our website to include
`clinical cases.
`
`The accreditation programme in transthoracic echocardiography is well established,
`and this year we started a similar scheme for transesophageal echocardiography in
`collaboration with the European Association of Cardiothoracic Anaesthesiology.
`Accreditation in echocardiography in congenital heart disease will start in 2006, in
`cooperation with the European Association of Paediatric Cardiology, and guidelines
`for laboratory standards are in preparation.
`
`Joint membership of the EAE with national subspecialty associations is being
`introduced, and in response to requests from outside the ESC we are establishing an
`international affiliate membership for some international echocardiographic societies.
`Close links with our professional counterparts worldwide, including North America,
`India, and Japan have been established.
`The European Journal of Echocardiography is developing under the editorship of
`Professor Jos Roelandt. Six issues annually are distributed to 1,600 people, with a
`profit that is shared between the publisher and the EAE.
`
`New guidelines initiatives and collaborative research projects are being developed as
`a major objective for the next year. In all activity areas this is in collaboration with
`colleagues in the other imaging Working Groups in the ESC and closer links in future
`can be expected.
`
`Alan Fraser
`President, European Association of Echocardiography
`
`13
`
`Liquidia's Exhibit 1105
`Page 12
`
`

`

`eEuropean Association for Cardiovascular Prevention
`
`& Rehabilitation (EACPR)
`
`The European Association for Cardiovascular Prevention and Rehabilitation (EACPR)
`was founded at the ESC Congress 2004 as a merger between Working Groups on
`Epidemiology & Prevention and on Cardiac Rehabilitation & Exercise Physiology with
`over 1,000 cardiologists and scientists from most European countries. Membership
`is open for cardiologists, other health professionals and scientists with an interest in
`epidemiology, prevention, rehabilitation, exercise physiology, sports cardiology, lifestyle
`studies, nutrition, etc.
`
`Its mission statement is:“To promote excellence in research, practice, education and
`policy in cardiovascular prevention and rehabilitation in Europe”. The Association
`offers coordination of current ESC efforts in the field of preventive cardiology by
`becoming an interface between different ESC bodies involved in prevention.
`
`During the period 2004-2006 an interim board consisting of nucleus members from
`the former Working Groups was created and a transition into a final structure will
`be established at our first main event: EuroPRevent 2006, Athens 11-13 May.
`
`Over the past year communication with our members has been established through
`the web site, newsletters, promotion at congresses and access to an educational slide
`database.The European Journal of Cardiovascular Prevention & Rehabilitation is the
`official journal and reports a rising impact factor.
`
`Members of the EACPR are engaged in a variety of projects such as HeartScore,
`EuroCardioRehab Data Standards, Heart Disease Health-Related Quality of Life
`(HRQL) Study and EuroAction. Several major initiatives are planned to start 2006
`including EuroAspire III and two European training courses. Thus, the EACPR has
`shown in the first year of its existence an ability to follow its mission statement as it
`strives to become the ESC stronghold for preventive cardiology!
`
`Joep Perk
`President, European Association for
`Cardiovascular Prevention and Rehabilitation
`
`14
`
`Liquidia's Exhibit 1105
`Page 13
`
`

`

`hHeart Failure Association (HFA) of the ESC
`
`The Heart Failure Association (HFA) of the ESC was officially launched in Munich on
`30 August 2004 and was created from the now dissolved ESC Working Group on
`Heart Failure.
`
`The HFA structure consists of the GENERAL ASSEMBLY and the BOARD, consisting
`of the Executive Committee, the Clinical Section and the Basic Sciences Section.
`The newly created HFA decided to 'broaden' the membership of the Board to also
`include 'basic scientists' and 'heart failure nurses'.
`
`In addition several ‘bottom-up’ type innovations were introduced through the
`formation of Committees (such as Executive Committee, Nominating Committee,
`Annual Congress Scientific Committee, Winter Meeting Organisation Committee,
`Heart Failure Management Network) and Study Groups which include Advanced
`Heart Failure, Acute Heart Failure, Diastolic Heart Failure and the Study Group on
`EU Proposals.
`
`V IIE%RT EACIERE
`
`ASSOCIATION
`OF THE ESC
`
`HFA Training Fellowships and Travel Grants
`The HFA grants two yearly HFA Training Fellowships of 12,000 Euros / 6 months
`each, for young cardiologists who wish to update their clinical training with modern
`cardiological methods, especially when it is impossible to learn particular techniques
`in their own country.
`
`The HFA offers Travel Grants of 400 Euros for congress participants less than 35
`years old. The applicant has to be an HFA member and his abstract should be
`accepted and presented by himself.
`
`Lisbon 2005
`The HFA Annual Congress in Lisbon on 11-14 June 2005, was exceptionally
`successful. The registration far exceeded 4,000 participants, the highest figure ever.
`Also the number of abstracts submitted was impressive, rising from the 765 abstracts
`of the 2004 meeting up to 1,195 abstracts this year.
`At this Congress the HFA Board has organised two meetings, one with
`representatives of industry and one with representatives of the National Societies.
`
`European Journal of Heart Failure
`Prof. John G.F. Cleland, as founder and first Editor-in-Chief of the European Journal
`of Heart Failure, has done an excellent job bringing the journal to an outstanding
`impact factor of 2.938 and making it the 13th most highly rated peer-reviewed
`cardiovascular journal in the world. As of January 1, 2005, the task of the Editor in
`
`15
`
`Liquidia's Exhibit 1105
`Page 14
`
`

`

`Chief has been assigned to another outstanding cardiologist and research leader in
`the field of heart failure, Prof. Karl Swedberg.
`
`Finances
`The revenues for the year 2003/2004 were e 554,399 / 522,399 from the 2003 HF
`meeting and 31,999 from the HF journal (as per August 13, 2004). For the years
`2004/2005 the profits are estimated to be at least e 135,000.
`
`Dirk L. Brutsaert
`President, Heart Failure Association of the ESC
`
`16
`
`Liquidia's Exhibit 1105
`Page 15
`
`

`

`eEuropean Union Relations
`
`2004 was an outstanding year for having brought cardiovascular disease high on the
`European agenda, with the unanimous adoption of conclusions on heart health by
`the Council of Health Ministers of the European Union.
`
`These Council Conclusions invited the European Commission and the Member
`States to take action in several fields of cardiovascular disease prevention.The ESC’s
`challenge was then to make sure that this major political progress for cardiovascular
`disease would not be forgotten; hence, the European Union Relations Committee
`focussed on the implementation of these Council Conclusions at national level.
`
`Conference on Heart Health
`One significant step in this implementation was the Conference on Heart Health
`organised by the European Commission’s Directorate General Public Health and
`Consumer Protection and the Luxembourg presidency in partnership with the ESC.
`This conference, which took place on 29 June 2005 in Luxembourg, was intended to
`“define comprehensive strategies for implementing Council Conclusions on Heart
`Health across Europe”. The EU Relations Committee organised the meeting,
`in
`partnership with the European Commission.
`It brought together high-level
`representatives in charge of public health matters in the Member States of the
`European Union and Candidate countries, as well as presidents of the national
`cardiac societies in the European Union and representatives of the European Heart
`Network, the WHO, the European Commission and the ESC.
`Participants were proposed practical solutions in the form of country strategies and
`basic tools for implementation; they were encouraged to seek consensus on
`common goals, create alliances within their respective countries and to commit on
`the implementation of heart health strategies.
`
`Women and Heart Disease
`Prevention of heart disease in women is also high on the European agenda thanks
`to the Austrian Ministry of Health and Women, which plans to organise a conference
`on this topic during their Presidency of the Council early in 2006.
`The “Women at Heart” campaign was launched in March 2005 and aims at
`developing awareness among the medical profession that women are more at risk
`than men.
`The ESC Congress 2005 in Stockholm has also dedicated numerous sessions to this
`topic.The outcome of the campaign will be used by a Steering Group (composed of
`officials from the Austrian Ministry of Health and Women and representatives of the
`Austrian Cardiac Society and the European Society of Cardiology) to identify the
`specific points where political support and action is needed and where consensus is
`
`17
`
`Liquidia's Exhibit 1105
`Page 16
`
`

`

`to be reached between the senior representatives of Health Ministries of the EU
`Member States in the Expert Conference in 2006.
`
`Research
`Cardiovascular research was at the centre of the discussions at a meeting with
`Members of the European Parliament earlier this year in Strasbourg. ESC
`representatives shared their views on the future of cardiovascular disease and
`expressed their wishes for the next Framework Programme 7 on research.
`The proposal from the European Commission for the above mentioned FP7,
`published in April, gave us the opportunity to collect the opinions of the ESC
`constituent bodies, the national cardiac societies, the Associations and the Working
`Groups as well as the pharmaceutical industry through the Task Force on Research
`of the Cardiovascular Round Table. Opinions expressed on this occasion were
`presented to the European Parliament. The Committee has established a lobby of
`sympathetic parliamentarians in Brussels.
`
`The last year has been valuable for establishing dialogue with members of the
`European Parliament and for consolidating the position of the ESC as one of the
`major stakeholders for all topics relating to cardiovascular diseases.
`
`18
`
`EU Flags
`
`European Community
`
`Liquidia's Exhibit 1105
`Page 17
`
`

`

`cCongress & Working Group Congresses
`
`The ESC Congress is the largest medical congress in Europe and among the top
`three cardiology meetings in the world. As such the congress is the cornerstone of
`the ESC’s commitment to science, research, training and education.
`
`The ESC Congress is unique in the sense that it has become an established forum
`for the exchange of science as much as education. During the congress we also
`welcome a growing number of basic scientists, nurses and allied professionals
`working in the field of cardiovascular care of patients.
`
`2C030
`ICODO -
`1 €03 C)
`143:10 -
`I2ODO -
`1c030 -
`0000
`
`Mal
`
`Ins Ilavi
`
`3;.)
`
`131-1 U .,
`
`ioco -
`2000 -
`
`2003 Vienna
`2000 Amsterdam
`2001 Stockholm
`1995 Amsterdam
`1996 Birmingham
`2002 Berlin
`1999 Barcelona
`1998 Vienna
`1997 Stockholm
`2003 Munich
`
`. F1ytit5'r 3 tzli&tui, n pletz
`
`The ESC Congress 2004 attracted professional attendance of over 18,000 for the
`third consecutive year. There was a total of 24,527 attendees comprised of 18,413
`professionals, 4,715 exhibitors, 636 journalists and 763 accompanying persons.
`
`All 47 ESC Member Countries were represented; attendance from non-European
`countries continues to increase, thus reflecting the worldwide recognition of the ESC
`Congress.
`ESC Member countries 78%
`USA & Canada
`6%
`Other
`16%
`
`The “Top Five” countries were Germany with 2,179 participants, France 1,365, Italy
`1,333, the United Kingdom with 1,001 and the United States of America with 908
`participants.
`
`The pharmaceutical, device and medical equipment industries once again made
`important contributions to the success of the 2004 Congress. More than 200
`organisations were represented in 12,032 m2 of exhibition space. Furthermore, 57
`
`19
`
`Liquidia's Exhibit 1105
`Page 18
`
`

`

`satellites and 8 workshop sessions were organised by industry as part of the scientific
`programme. Of these 65 sessions 14 were successfully transformed into EBAC
`Accredited Educational Programmes, an initiative launched at the ESC Congress
`2004.
`
`The electronic presentation of selected abstracts was introduced for the first time.
`These “e-posters” were the standard format for all posters in the Basic Science,
`Magnetic Resonance Imaging, Nuclear Cardiology and Computers in Cardiology
`categories.
`The city of Munich and the Messe München played host to the ESC Congress for
`the first time and a new level of excellence has been established as a benchmark for
`future events.
`
`ESC Annual Congress 2005
`The Congress, to be held in Stockholm, will cover the various aspects of
`cardiovascular diseases and will be an international forum where all physicians,
`scientists, nurses, and other professionals concerned by this specialty can exchange
`information and expertise.
`It will include 161 pre-arranged sessions including twenty-four special sessions (nine
`of which are jointly organised with other scientific organisations) and 127 oral
`abstract sessions.
`The highlight of the Congress will be “Women at Heart” in order to emphasize the
`importance of cardiovascular diseases in women and explore the modalities of their
`diagnosis and management. Several pre-arranged sessions on this topic have been
`organised and will be labelled by a special logo.
`Two initiatives will be taken in Stockholm:
`- the Science Hot Line will be a special session in which up-to-date new scientific
`results from six finalists will be presented and a jury will identify the winner.
`- three “meet the experts” lunch sessions will be organised around case
`presentations and reference to ESC guidelines.
`A record submission of 9,028 abstracts was observed in 2005. 2,985 abstracts have
`been selected by the Congress Programme Committee (acceptance rate of 33 %)
`including 1,710 posters, 56 moderated posters, 399 e-posters and 54 moderated e-
`posters.The ten countries with the greatest number of abstracts accepted are Italy,
`Germany, France, the United Kingdom, the Netherlands, Spain, Greece, Poland, the
`United States of America and Japan.
`Additional time slots for e-posters will be available and attention has been paid to
`the visibility of this 2004 initiative in order to ensure a better interaction between
`presenters and participants.
`
`20
`
`Liquidia's Exhibit 1105
`Page 19
`
`

`

`jJournals
`
`ESC Journals in 2005
`
`Cardiovascular Research
`CVR continues to prosper and online usage is increasing. CVR has 50,000+ full-text
`article downloads per month. Impact Factor increased from 4.692 to 5.164. ESC
`member subscriptions remain steady.
`
`European Heart Journal
`Articles submitted to the editorial office increased significantly in 2004 to more than
`1,950 per year, representing a 20% increase on 2003. Impact Factor dropped from
`6.131 to 5.997 for 2003, but for 2004 it has risen to 6.247.
`The publication of EHJ went for tender and Oxford University Press won the new
`contract from 2005.
`
`European Journal of Heart Failure
`(Journal of the Heart Failure Association of the European Society of Cardiology)
`Impact Factor increased to 2.938 resulting in submissions doubling from 2003 to
`2004. Subscriptions grew and online usage via libraries increased with 98,000+
`articles downloaded.
`
`Professor Karl Swedberg became the Editor-in-Chief, replacing Professor John
`Cleland, who stays as a Consultant and Editorial Board Member.
`
`EUROPACE
`(Journal of the European Heart Rhythm Association, a Registered Branch of the ESC
`and the ESC Working Group on Cardiac Cellular Electrophysiology)
`
`The Impact Factor increased from 0.971 to 1.089 in 2003. Institutional subscribers
`and online usage grew, with article downloads tripling to c. 29,000.
`
`European Journal of Echocardiography
`(Journal of the European Association of Echocardiography of the European Society
`of Cardiology)
`
`Subscribers have grown significantly to 1,801 in 2004; concurrently online usage has
`doubled to